Short-term Intravenous Iron Isomaltose Anhydride for IDA

Summary

This prospective, randomized, controlled study aims to evaluate the impact of short-term intravenous iron isomaltose anhydride on postoperative recovery and the requirement for allogeneic red blood cells (RBC) transfusion in preoperative Iron-deficiency anemia (IDA) patients receiving orthopedic surgery, thus facilitating developing a simple and effective iron supplement approach for patients' recovery.

Timeline

Start

2024-07-05

Primary completion

2028-05-31

Completion

2029-05-31

Drugs

Indications